Zoxton-T 1.125 Injection
Marketer
Ampira Biotechnics Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Zoxton-T 1.125 Injection
Combiflox-T 1.125 Injection, a multi-component medication, combats various bacterial infections. Its action inhibits microbial proliferation, thus limiting infection spread. Administration must be under a physician's direct supervision. Strictly adhere to the prescribed dosage schedule; complete the entire course, even with symptom improvement. Premature cessation can compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing somnolence or vertigo. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Your physician may order laboratory and diagnostic tests to monitor the medication's effects.
Primary Ingredients of Zoxton-T 1.125 Injection
No text provided to rephrase.
Uses of Zoxton-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Zoxton-T 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Zoxton-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Zoxton-T 1.125 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Zoxton-T 1.125 Injection works:
Zoxton-T 1.125 Injection unites Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Zoxton-T 1.125 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Zoxton-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Zoxton-T 1.125 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Zoxton-T 1.125 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Zoxton-T 1.125 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Zoxton-T 1.125 Injection to individuals with severe hepatic impairment requires careful consideration. Dosage modification of Zoxton-T 1.125 Injection might be necessary; physician consultation is advised. Altering the Zoxton-T 1.125 Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Zoxton-T 1.125 Injection :
Omitting a scheduled Zoxton-T 1.125 Injection requires immediate physician consultation.
Facts to Know About Zoxton-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently